AAPG
Price
$17.26
Change
-$0.75 (-4.16%)
Updated
Jul 31 closing price
Capitalization
1.61B
23 days until earnings call
Intraday BUY SELL Signals
NGNE
Price
$32.97
Change
+$0.08 (+0.24%)
Updated
Aug 3, 11:45 AM (EDT)
Capitalization
656.17M
4 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AAPG vs NGNE

AAPG vs NGNE Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
AAPG vs. NGNE commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AAPG is a Buy and NGNE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 03, 2026
Stock price -- (AAPG: $17.26 vs. NGNE: $32.89)
Brand notoriety: AAPG and NGNE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AAPG: 19% vs. NGNE: 56%
Market capitalization -- AAPG: $1.61B vs. NGNE: $656.17M
AAPG [@Biotechnology] is valued at $1.61B. NGNE’s [@Biotechnology] market capitalization is $656.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.09B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AAPG’s FA Score shows that 0 FA rating(s) are green whileNGNE’s FA Score has 0 green FA rating(s).

  • AAPG’s FA Score: 0 green, 5 red.
  • NGNE’s FA Score: 0 green, 5 red.
According to our system of comparison, NGNE is a better buy in the long-term than AAPG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AAPG’s TA Score shows that 4 TA indicator(s) are bullish while NGNE’s TA Score has 3 bullish TA indicator(s).

  • AAPG’s TA Score: 4 bullish, 6 bearish.
  • NGNE’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both AAPG and NGNE are a bad buy in the short-term.

Price Growth

AAPG (@Biotechnology) experienced а -6.45% price change this week, while NGNE (@Biotechnology) price change was -5.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.22%. For the same industry, the average monthly price growth was -8.12%, and the average quarterly price growth was +2790.29%.

Reported Earning Dates

AAPG is expected to report earnings on Aug 26, 2026.

NGNE is expected to report earnings on Aug 07, 2026.

Industries' Descriptions

@Biotechnology (-1.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AAPG($1.61B) has a higher market cap than NGNE($656M). NGNE YTD gains are higher at: 59.660 vs. AAPG (-34.223). NGNE has higher annual earnings (EBITDA): -95.45M vs. AAPG (-1.09B). AAPG has more cash in the bank: 1.66B vs. NGNE (243M). NGNE has less debt than AAPG: NGNE (9.54M) vs AAPG (1.72B). AAPG has higher revenues than NGNE: AAPG (391M) vs NGNE (0).
AAPGNGNEAAPG / NGNE
Capitalization1.61B656M245%
EBITDA-1.09B-95.45M1,137%
Gain YTD-34.22359.660-57%
P/E RatioN/AN/A-
Revenue391M0-
Total Cash1.66B243M684%
Total Debt1.72B9.54M17,989%
FUNDAMENTALS RATINGS
NGNE: Fundamental Ratings
NGNE
OUTLOOK RATING
1..100
93
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AAPGNGNE
RSI
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
68%
Bullish Trend 4 days ago
80%
Momentum
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
81%
MACD
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
86%
Advances
ODDS (%)
Bullish Trend 13 days ago
67%
Bullish Trend 15 days ago
86%
Declines
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
80%
Aroon
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
AAPG
Daily Signal:
Gain/Loss:
NGNE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CPXR31.820.41
+1.31%
Uscf Daily Target 2X Copper Index ETF
SMMU50.270.01
+0.02%
PIMCO Short Term Municipal Bond Actv ETF
FTBI21.52N/A
+0.02%
First Trust Balanced Income ETF
GRN32.60N/A
N/A
iPath® Series B Carbon ETN
DMB10.52-0.05
-0.47%
BNY Mellon Municipal

AAPG and

Correlation & Price change

A.I.dvisor tells us that AAPG and NGNE have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AAPG and NGNE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AAPG
1D Price
Change %
AAPG100%
-4.16%
NGNE - AAPG
21%
Poorly correlated
-2.11%
ACTU - AAPG
21%
Poorly correlated
-5.13%
RCKT - AAPG
21%
Poorly correlated
-3.12%
SRPT - AAPG
20%
Poorly correlated
-4.50%
BCYC - AAPG
20%
Poorly correlated
-3.74%
More